Beyond Weight Loss: Association Between Glucagon-like peptide-1 Receptor Agonist Therapy and Incidence of Facial and Oculoplastic Procedures

Key Points

• To evaluate the long-term effects of GLP-1 RA therapy on the incidence of facial and oculoplastic procedures in patients with type 2 diabetes mellitus.
• Analyzed data on facial and oculoplastic procedures among patients receiving GLP-1 RA therapy.
• Considered long-term outcomes and frequency of procedures in the target population.
• GLP-1 RA therapy correlates with a higher long-term incidence of facial procedures.
• Increased need for oculoplastic procedures is noted in the therapeutic group.

Abstract